ITCI
Arrowstreet Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-79,287
| Closed | -$10.5M | – | 2136 |
|
|
2025
Q1 | $10.5M | Buy |
+79,287
| New | +$10.5M | 0.01% | 798 |
|
|
2024
Q3 | – | Sell |
-3,906
| Closed | -$268K | – | 1909 |
|
|
2024
Q2 | $268K | Buy |
+3,906
| New | +$268K | ﹤0.01% | 1415 |
|
|
2023
Q3 | – | Sell |
-9,671
| Closed | -$612K | – | 1458 |
|
|
2023
Q2 | $612K | Buy |
+9,671
| New | +$612K | ﹤0.01% | 1041 |
|
|
2022
Q3 | – | Sell |
-9,238
| Closed | -$527K | – | 1489 |
|
|
2022
Q2 | $527K | Sell |
9,238
-4,663
| -34% | -$266K | ﹤0.01% | 1061 |
|
|
2022
Q1 | $851K | Buy |
+13,901
| New | +$851K | ﹤0.01% | 964 |
|
|
2020
Q4 | – | Sell |
-21,919
| Closed | -$562K | – | 2585 |
|
|
2020
Q3 | $562K | Buy |
+21,919
| New | +$562K | ﹤0.01% | 1987 |
|
|
2020
Q1 | – | Sell |
-8,700
| Closed | -$298K | – | 2167 |
|
|
2019
Q4 | $298K | Buy |
+8,700
| New | +$298K | ﹤0.01% | 1570 |
|
|
2016
Q4 | – | Sell |
-17,990
| Closed | -$274K | – | 2601 |
|
|
2016
Q3 | $274K | Buy |
+17,990
| New | +$274K | ﹤0.01% | 1365 |
|